City
Epaper

WHO releases 1st-ever guidance on clinical management of diphtheria

By IANS | Updated: February 15, 2024 12:05 IST

Geneva, Feb 15 In a first, the World Health Organization (WHO) has released guidance on the clinical management ...

Open in App

Geneva, Feb 15 In a first, the World Health Organization (WHO) has released guidance on the clinical management of diphtheria.

While previous available guidance was just an operational protocol, the new guidance followed the rigorous process for developing guidance at WHO.

It addresses the use of Diphtheria Antitoxin (DAT) in the treatment of diphtheria.

The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.

“This clinical practice guideline has been rapidly developed recognising the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria,” the WHO said.

“Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving,” the agency noted.

Diphtheria is a disease caused by a bacterium that affects the upper respiratory tract and less often the skin. It also produces a toxin that damages the heart and the nerves.

It is a vaccine preventable disease, but multiple doses and booster doses are needed to produce and sustain immunity. People who are not immunised or under immunised are at risk of the disease.

Diphtheria is fatal in 5-10 per cent of cases, with a higher mortality rate in young children.

Recent diphtheria outbreaks stress the importance of sustaining high levels of vaccination coverage in communities across the life course.

In 2022, an estimated 84 per cent of children worldwide received the recommended 3 doses of diphtheria-containing vaccine during infancy, leaving 16 per cent with no or incomplete coverage. There is wide coverage variation between and within countries.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalLaos prepares for Lao New Year with emphasis on safety, cultural heritage

Technology'Womaniya' initiative leads 2.1 lakh women MSEs onto GeM with 13.7 lakh orders

Business'Womaniya' initiative leads 2.1 lakh women MSEs onto GeM with 13.7 lakh orders

National'Womaniya' initiative leads 2.1 lakh women MSEs onto GeM with 13.7 lakh orders

NationalThree-year-old boy trapped in borewell in MP's Ujjain; rescue operation underway

Health Realted Stories

HealthAnganwadi centres serving nearly 8.9 crore beneficiaries: Minister

Health2,527 eateries inspected, 703 kg of food destroyed as Gujarat steps up paneer–analogue checks

HealthJayant Patil urges Maha govt to scrap DPT vaccine strain sale​

HealthHealth Tips: How to Increase Hemoglobin Levels With Simple Food Pairings

HealthAssam Rifles seizes smuggled haul of rare medicinal plant in Mizoram, apprehends three